455 related articles for article (PubMed ID: 28826542)
1. Cannabinoids as Anticancer Drugs.
Ramer R; Hinz B
Adv Pharmacol; 2017; 80():397-436. PubMed ID: 28826542
[TBL] [Abstract][Full Text] [Related]
2. Antitumorigenic targets of cannabinoids - current status and implications.
Ramer R; Hinz B
Expert Opin Ther Targets; 2016 Oct; 20(10):1219-35. PubMed ID: 27070944
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumour actions of cannabinoids.
Hinz B; Ramer R
Br J Pharmacol; 2019 May; 176(10):1384-1394. PubMed ID: 30019449
[TBL] [Abstract][Full Text] [Related]
4. The Endocannabinoid System: A Target for Cancer Treatment.
Laezza C; Pagano C; Navarra G; Pastorino O; Proto MC; Fiore D; Piscopo C; Gazzerro P; Bifulco M
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979368
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoids as anticancer drugs: current status of preclinical research.
Hinz B; Ramer R
Br J Cancer; 2022 Jul; 127(1):1-13. PubMed ID: 35277658
[TBL] [Abstract][Full Text] [Related]
6. The use of cannabinoids as anticancer agents.
Velasco G; Hernández-Tiedra S; Dávila D; Lorente M
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():259-66. PubMed ID: 26071989
[TBL] [Abstract][Full Text] [Related]
7. Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas.
Fraguas-Sánchez AI; Fernández-Carballido A; Torres-Suárez AI
Expert Opin Investig Drugs; 2016 Nov; 25(11):1311-1323. PubMed ID: 27633508
[TBL] [Abstract][Full Text] [Related]
8. Targeting the endocannabinoid system for the treatment of cancer--a practical view.
Fowler CJ; Gustafsson SB; Chung SC; Persson E; Jacobsson SO; Bergh A
Curr Top Med Chem; 2010; 10(8):814-27. PubMed ID: 20370711
[TBL] [Abstract][Full Text] [Related]
9. Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion (review).
Bifulco M; Laezza C; Gazzerro P; Pentimalli F
Oncol Rep; 2007 Apr; 17(4):813-6. PubMed ID: 17342320
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoids, endocannabinoids, and cancer.
Hermanson DJ; Marnett LJ
Cancer Metastasis Rev; 2011 Dec; 30(3-4):599-612. PubMed ID: 22038019
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies?
Oesch S; Gertsch J
J Pharm Pharmacol; 2009 Jul; 61(7):839-53. PubMed ID: 19589225
[TBL] [Abstract][Full Text] [Related]
12. New insights into antimetastatic and antiangiogenic effects of cannabinoids.
Ramer R; Hinz B
Int Rev Cell Mol Biol; 2015; 314():43-116. PubMed ID: 25619715
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators.
Brown I; Cascio MG; Rotondo D; Pertwee RG; Heys SD; Wahle KW
Prog Lipid Res; 2013 Jan; 52(1):80-109. PubMed ID: 23103355
[TBL] [Abstract][Full Text] [Related]
14. Endocannabinoids and Cancer.
Velasco G; Sánchez C; Guzmán M
Handb Exp Pharmacol; 2015; 231():449-72. PubMed ID: 26408171
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid receptor systems: therapeutic targets for tumour intervention.
Jones S; Howl J
Expert Opin Ther Targets; 2003 Dec; 7(6):749-58. PubMed ID: 14640910
[TBL] [Abstract][Full Text] [Related]
16. Endocannabinoids as Guardians of Metastasis.
Tegeder I
Int J Mol Sci; 2016 Feb; 17(2):230. PubMed ID: 26875980
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoids as Prospective Anti-Cancer Drugs: Mechanism of Action in Healthy and Cancer Cells.
Boyacıoğlu Ö; Korkusuz P
Adv Exp Med Biol; 2023; 1410():145-169. PubMed ID: 36396926
[TBL] [Abstract][Full Text] [Related]
18. Cannabis and its constituents for cancer: History, biogenesis, chemistry and pharmacological activities.
Lal S; Shekher A; Puneet ; Narula AS; Abrahamse H; Gupta SC
Pharmacol Res; 2021 Jan; 163():105302. PubMed ID: 33246167
[TBL] [Abstract][Full Text] [Related]
19. [The endocannabinoid system as a target for the development of new drugs for cancer therapy].
Bifulco M; Di Marzo V
Recenti Prog Med; 2003 May; 94(5):194-8. PubMed ID: 12723496
[TBL] [Abstract][Full Text] [Related]
20. The potential of cannabinoids and inhibitors of endocannabinoid degradation in respiratory diseases.
Kicman A; Pędzińska-Betiuk A; Kozłowska H
Eur J Pharmacol; 2021 Nov; 911():174560. PubMed ID: 34648805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
